249 related articles for article (PubMed ID: 36597018)
1. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study.
Choi S; Kim BK; Yon DK; Lee SW; Lee HG; Chang HH; Park S; Koyanagi A; Jacob L; Dragioti E; Radua J; Shin JI; Kim SU; Smith L
Clin Mol Hepatol; 2023 Apr; 29(2):433-452. PubMed ID: 36597018
[TBL] [Abstract][Full Text] [Related]
2. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Cirrhosis Collaborators
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
[TBL] [Abstract][Full Text] [Related]
3. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
[TBL] [Abstract][Full Text] [Related]
4. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019.
Golabi P; Paik JM; AlQahtani S; Younossi Y; Tuncer G; Younossi ZM
J Hepatol; 2021 Oct; 75(4):795-809. PubMed ID: 34081959
[TBL] [Abstract][Full Text] [Related]
5. Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990-2019.
Ghamari SH; Yoosefi M; Abbasi-Kangevari M; Malekpour MR; Saeedi Moghaddam S; Shahin S; Esfahani Z; Koolaji S; Shobeiri P; Ghaffari A; Sohrabi H; Kazemi A; Rezaei N; Larijani B; Farzadfar F
Hepatol Commun; 2022 Jul; 6(7):1764-1775. PubMed ID: 35134275
[TBL] [Abstract][Full Text] [Related]
6. Global Burden and Trends of Primary Liver Cancer Attributable to Comorbid Type 2 Diabetes Mellitus Among People Living with Hepatitis B: An Observational Trend Study from 1990 to 2019.
Xie J; Lin X; Fan X; Wang X; Pan D; Li J; Hao Y; Jie Y; Zhang L; Gu J
J Epidemiol Glob Health; 2024 May; ():. PubMed ID: 38713342
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data.
Rezaei F; Mazidimoradi A; Rayatinejad A; Allahqoli L; Salehiniya H
Thorac Cancer; 2023 Jun; 14(18):1668-1706. PubMed ID: 37127553
[TBL] [Abstract][Full Text] [Related]
8. The burden of brain and central nervous system cancers in Asia from 1990 to 2019 and its predicted level in the next twenty-five years : Burden and prediction model of CNS cancers in Asia.
Liu X; Cheng LC; Gao TY; Luo J; Zhang C
BMC Public Health; 2023 Dec; 23(1):2522. PubMed ID: 38104107
[TBL] [Abstract][Full Text] [Related]
9. The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.
Chen H; Zhan Y; Zhang J; Cheng S; Zhou Y; Chen L; Zeng Z
JMIR Public Health Surveill; 2022 Dec; 8(12):e34809. PubMed ID: 36508249
[TBL] [Abstract][Full Text] [Related]
10. Burden of liver cancer due to hepatitis C from 1990 to 2019 at the global, regional, and national levels.
Wei J; Ouyang G; Huang G; Wang Y; Li S; Liu J; Zhang Y; Yuan G; He S
Front Oncol; 2023; 13():1218901. PubMed ID: 38170051
[TBL] [Abstract][Full Text] [Related]
11. Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.
Tan DJH; Setiawan VW; Ng CH; Lim WH; Muthiah MD; Tan EX; Dan YY; Roberts LR; Loomba R; Huang DQ
Hepatology; 2023 Apr; 77(4):1150-1163. PubMed ID: 36037274
[TBL] [Abstract][Full Text] [Related]
12. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.
Huang DQ; Singal AG; Kono Y; Tan DJH; El-Serag HB; Loomba R
Cell Metab; 2022 Jul; 34(7):969-977.e2. PubMed ID: 35793659
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomics and attributable etiology of primary liver cancer, 1990-2019.
Xing QQ; Li JM; Dong X; Zeng DY; Chen ZJ; Lin XY; Pan JS
World J Gastroenterol; 2022 Jun; 28(21):2361-2382. PubMed ID: 35800181
[TBL] [Abstract][Full Text] [Related]
14. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
[TBL] [Abstract][Full Text] [Related]
15. Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019.
Wang D; Xu Y; Zhu Z; Li Y; Li X; Li Y; Shen H; Wu W; Liu Y; Han C
Front Nutr; 2022; 9():1047129. PubMed ID: 36618688
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.
GBD 2019 Europe Hepatitis B & C Collaborators
Lancet Public Health; 2023 Sep; 8(9):e701-e716. PubMed ID: 37633679
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.
Deng Y; Zhao P; Zhou L; Xiang D; Hu J; Liu Y; Ruan J; Ye X; Zheng Y; Yao J; Zhai Z; Wang S; Yang S; Wu Y; Li N; Xu P; Zhang D; Kang H; Lyu J; Dai Z
J Hematol Oncol; 2020 Jul; 13(1):98. PubMed ID: 32690044
[TBL] [Abstract][Full Text] [Related]
18. Global, regional, and national burden of ovarian cancer and the attributable risk factors in all 194 countries and territories during 2007-2017: A systematic analysis of the Global Burden of Disease Study 2017.
Yang D; Huang H; Ruan T; Yang H; Hu J; Xu S; Ling S; Yu Y
J Obstet Gynaecol Res; 2021 Dec; 47(12):4389-4402. PubMed ID: 34674356
[TBL] [Abstract][Full Text] [Related]
19. Burden of liver complications related to non-alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019.
Liu H; Qi J; Yang J; Liu F; Li X; Yin P; Wang L; Liang Z; Wei L; Rao H; Zhou M
Diabetes Obes Metab; 2023 Apr; 25 Suppl 1():43-52. PubMed ID: 36781698
[TBL] [Abstract][Full Text] [Related]
20. The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017.
Zhai M; Liu Z; Long J; Zhou Q; Yang L; Zhou Q; Liu S; Dai Y
Sci Rep; 2021 Mar; 11(1):5195. PubMed ID: 33664363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
